Clinical trials
Phase 2 Parkinson Disease trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 3 |
| 2004 | 2 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 2 |
| 2015 | 1 |
| 2016 | 4 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
| Active, not recruiting | 7 |
| Terminated | 6 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 3 |
| Biogen | 2 |
| Hoffmann-La Roche | 2 |
| Sanofi | 2 |
| UCB Biopharma SRL | 2 |
| AC Immune SA | 1 |
| Bayer | 1 |
| Bial R&D Investments, S.A. | 1 |
| BioArctic AB | 1 |
| Boehringer Ingelheim | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Parkinson Disease | 35 |
| Movement Disorders | 6 |
| Dyskinesias | 4 |
| Parkinsonian Disorders | 4 |
| Neurodegenerative Diseases | 2 |
| Basal Ganglia Diseases | 1 |
| Central Nervous System Diseases | 1 |
| Dyskinesia, Drug-Induced | 1 |
| Multiple System Atrophy | 1 |
| Tremor | 1 |
Trials
Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.